CA 27.29 Test

Cancer antigen 27.29, usually written as CA 27.29, is a protein that some tissues can release into the bloodstream, where a laboratory can measure the overall amount present. The CA 27.29 test reports that amount as a single piece of information. It looks at the same underlying protein family as some other breast-associated markers, and like them it is general rather than a picture of any one organ, so a clinician always reads it alongside everything else they know about a person.

The test is done with a routine blood draw at a Quest patient service center. A phlebotomist collects a sample from a vein, usually in the arm, and sends it to the laboratory for analysis. CA 27.29 is most useful when followed across time rather than as a one-time check, so the same test may be repeated at intervals. Results are read by a clinician in light of history, prior readings, and other findings.

People who consider a CA 27.29 test are usually already working with a clinician who has suggested following this marker as part of ongoing care. It is not typically used as a general screening test for people without a specific reason, because the marker can move for many everyday causes and is not reliable for finding disease early on its own. Anyone thinking about this test often talks it through with a clinician first, since its usefulness depends on the individual situation and on how the result fits with the rest of the picture.

The CA 27.29 test reflects the amount of one specific protein in the blood, not the overall health of any single part of the body. Because more than one kind of tissue can contribute to the amount measured, the marker is best understood as a general signal a clinician weighs rather than a direct reading of one organ.

It is not a hormone and it is not an image of anything internal. It is simply a protein that circulates and can vary, which is why the result carries meaning only when a clinician places it next to a person's history and other information.

A CA 27.29 result cannot diagnose cancer, and it cannot rule it out. It is a monitoring marker, which means it can help a clinician follow a situation over time, but it does not settle any question by itself.

CA 27.29 can be raised for many reasons that have nothing to do with cancer, including benign breast and liver conditions, inflammation, and other common causes. It can also sit within an unremarkable range even when something is present, so a single reading is never taken as an answer. A clinician reads the result against history, symptoms, and other findings, and any diagnosis, when needed, involves further evaluation such as imaging and sometimes a biopsy.

The most common use of CA 27.29 is to watch how the marker changes across more than one point in time. A clinician may pay more attention to the trend, such as whether the marker is steady, rising, or falling, than to any single value, because the pattern can add context that a one-time reading cannot.

For this reason the CA 27.29 test is frequently ordered on a repeating schedule for people already under a clinician's care, sometimes during and after treatment. In every use, it supports a conversation about whether anything is worth exploring further; it guides next steps rather than providing conclusions on its own.

No appointment is usually needed. People can walk into a Quest patient service center during open hours, and the blood draw itself is quick. Because benign conditions can influence CA 27.29, it can help to mention relevant history, current medications, and any prior readings so a clinician has full context. Once the laboratory completes its analysis, results are posted to your account, where they can be reviewed privately and shared with a clinician.

Results will be emailed securely to you as a PDF.